Nov 08, 2017 12:31 pm UTC| Business
Saint Petersburg, FL, Nov. 08, 2017 -- Nuvus.io, a division of Nuvus Corp, is a decentralized blockchain company formed to build big data and supply chain verification ecosystem using distributive ledger technologies...
Avadel Pharmaceuticals Reports Third Quarter 2017 Results
Nov 08, 2017 12:31 pm UTC| Business
Total Revenues for the Third Quarter Were $39.7 Million Full Year Revenue Guidance of $165-$175 Million Unchanged Acquired License for Noctiva™ DUBLIN, Ireland, Nov. 08, 2017 -- Avadel Pharmaceuticals plc...
TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2017 Financial Results
Nov 08, 2017 12:31 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced its financial results for the third quarter ended September 30, 2017, and recent company developments. Michael S. Weiss, the Company's...
Nov 08, 2017 12:31 pm UTC| Business
GERMANTOWN, Md., Nov. 08, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced the appointment of David Recker, MD, FACR, FACP, as...
Tyme Provides Clinical and Corporate Update for the Fiscal First Half 2017
Nov 08, 2017 12:31 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- Tyme Technologies, Inc. (Nasdaq:TYME), a clinical-stage biotechnology company developing cancer therapeutics, today announced an update of its clinical and corporate progress for the first...
Nov 08, 2017 12:31 pm UTC| Business
JOHNS CREEK, Ga., Nov. 08, 2017 -- Ebix, Inc. (NASDAQ:EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, e-governance and healthcare industries, today...
Nov 08, 2017 12:31 pm UTC| Business
ATLANTA, Nov. 08, 2017 -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that data from nine ILUVIEN®...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update